Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Clinical Characteristics and Risk of Exacerbations Associated With Different Diagnostic Criteria of Asthma-COPD Overlap.

Soler-Cataluña JJ, Novella L, Soler C, Nieto ML, Esteban V, Sánchez-Toril F, Miravitlles M.

Arch Bronconeumol. 2019 Nov 26. pii: S0300-2896(19)30392-8. doi: 10.1016/j.arbres.2019.08.023. [Epub ahead of print] English, Spanish.

2.

EVALUATION OF CHANGES IN CONTROL STATUS IN COPD: AN OPPORTUNITY FOR EARLY INTERVENTION: Control status is useful for clinical assessment.

Soler-Cataluña JJ, Alcazar B, Marzo M, Pérez J, Miravitlles M.

Chest. 2019 Nov 21. pii: S0012-3692(19)34222-9. doi: 10.1016/j.chest.2019.11.004. [Epub ahead of print]

PMID:
31759964
3.

Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter study.

Kim KY, Miravitlles M, Sliwinski P, Costello R, Carter V, Tan J, Lapperre TS, Alcazar B, Gouder C, Esquinas C, García-Rivero JL, Kemppinen A, Tee A, Roman-Rodríguez M, Soler-Cataluña JJ, Price D, Rhee CK.

Int J Chron Obstruct Pulmon Dis. 2019 Jul 25;14:1595-1601. doi: 10.2147/COPD.S208245. eCollection 2019.

4.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2019 Report: Future Challenges.

López-Campos JL, Soler-Cataluña JJ, Miravitlles M.

Arch Bronconeumol. 2019 Jul 15. pii: S0300-2896(19)30275-3. doi: 10.1016/j.arbres.2019.06.001. [Epub ahead of print] English, Spanish. No abstract available.

5.

Clinical Control in COPD: A New Therapeutic Objective?

Soler-Cataluña JJ, Alcázar B, Miravitlles M.

Arch Bronconeumol. 2019 Jul 10. pii: S0300-2896(19)30278-9. doi: 10.1016/j.arbres.2019.06.004. [Epub ahead of print] English, Spanish. No abstract available.

6.

Patients with Chronic Obstructive Pulmonary Disease Exacerbations: Recommendations for Diagnosis, Treatment and Care.

Alcázar Navarrete B, Ancochea Bermúdez J, García-Río F, Izquierdo Alonso JL, Miravitlles M, Rodríguez González-Moro JM, Soler-Cataluña JJ.

Arch Bronconeumol. 2019 Sep;55(9):478-487. doi: 10.1016/j.arbres.2019.02.020. Epub 2019 Apr 6. English, Spanish.

7.

External Validation and Recalculation of the CODEX Index in COPD Patients. A 3CIAplus Cohort Study.

Almagro P, Martínez-Camblor P, Miravitlles M, Rodríguez-Carballeira M, Navarro A, Lamprecht B, Ramirez-Garcia Luna AS, Kaiser B, Alfageme I, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Celli BR, Marin JM, Ter Riet G, Sobradillo P, Lange P, Garcia-Aymerich J, Anto JM, Turner AM, Han MK, Langhammer A, Sternberg A, Leivseth L, Bakke P, Johannessen A, Oga T, Cosío B, Ancochea J, Echazarreta A, Roche N, Burgel PR, Sin DD, Puhan MA, Soriano JB; 3CIA collaboration.

COPD. 2019 Feb;16(1):8-17. doi: 10.1080/15412555.2018.1484440. Epub 2019 Mar 14.

PMID:
30870059
8.

Correction: Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study.

Calle Rubio M, Soriano JB, López-Campos JL, Soler-Cataluña JJ, Alcázar Navarrete B, Rodríguez González-Moro JM, Miravitlles M, Barrecheguren M, Fuentes Ferrer ME, Hermosa JLR; EPOCONSUL Study.

PLoS One. 2019 Feb 12;14(2):e0212522. doi: 10.1371/journal.pone.0212522. eCollection 2019.

9.

Assessing the clinical practice in specialized outpatient clinics for chronic obstructive pulmonary disease: Analysis of the EPOCONSUL clinical audit.

Calle Rubio M, Soler-Cataluña JJ, López-Campos JL, Alcázar Navarrete B, Rodríguez González-Moro JM, Soriano JB, Fuentes Ferrer ME, Rodriguez Hermosa JL.

PLoS One. 2019 Feb 6;14(2):e0211732. doi: 10.1371/journal.pone.0211732. eCollection 2019.

10.

10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain -A Summary of the EPISCAN II Protocol.

Alfageme I, de Lucas P, Ancochea J, Miravitlles M, Soler-Cataluña JJ, García-Río F, Casanova C, Rodríguez González-Moro JM, Cosío BG, Sánchez G, Soriano JB.

Arch Bronconeumol. 2019 Jan;55(1):38-47. doi: 10.1016/j.arbres.2018.05.011. Epub 2018 Jul 7. English, Spanish.

11.

Increased Incidence of Stroke, but Not Coronary Heart Disease, in Elderly Patients With Sleep Apnea.

Catalan-Serra P, Campos-Rodriguez F, Reyes-Nuñez N, Selma-Ferrer MJ, Navarro-Soriano C, Ballester-Canelles M, Soler-Cataluña JJ, Roman-Sanchez P, Almeida-Gonzalez CV, Martinez-Garcia MA.

Stroke. 2019 Feb;50(2):491-494. doi: 10.1161/STROKEAHA.118.023353.

PMID:
30580706
12.

Validation of clinical control in COPD as a new tool for optimizing treatment.

Soler-Cataluña JJ, Marzo M, Catalán P, Miralles C, Alcazar B, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2018 Nov 14;13:3719-3731. doi: 10.2147/COPD.S178149. eCollection 2018.

13.

Determinants of the Appearance and Progression of Early-Onset Chronic Obstructive Pulmonary Disease in Young Adults. A Case-Control Study with Follow-up.

Borràs-Santos A, Garcia-Aymerich J, Soler-Cataluña JJ, Vigil Giménez L, Gea Guiral J, Rodríguez Chiaradía D, Pascual-Guardia S, Marcos Rodríguez PJ, Alvarez Martinez CJ, Casanova Macario C, López-Campos JL, Carrasco Hernández L, Martínez-González C, Santos-Pérez S, Peces-Barba G, Molina Paris J, Román Rodríguez M, Barberà JA, Faner R, Agustí A, Cosío BG; en representación del Grupo Investigador del estudio EARLY COPD.

Arch Bronconeumol. 2019 Jun;55(6):312-318. doi: 10.1016/j.arbres.2018.09.007. Epub 2018 Nov 11. English, Spanish.

14.

[Available resources for the management of chronic obstructive pulmonary disease exacerbations in Spain].

Soler-Cataluña JJ, Fernández Villar A, Piñera Salmerón PL, Román-Rodríguez M, Huerta Hernández A, Roset Gamisans M.

Semergen. 2018 Oct;44(7):449-457. doi: 10.1016/j.semerg.2018.03.010. Epub 2018 Sep 8. Spanish.

PMID:
30206038
15.

Determinants of medical prescriptions for COPD care: an analysis of the EPOCONSUL clinical audit.

Lopez-Campos JL, Navarrete BA, Soriano JB, Soler-Cataluña JJ, González-Moro JMR, Ferrer MEF, Rubio MC.

Int J Chron Obstruct Pulmon Dis. 2018 Jul 27;13:2279-2288. doi: 10.2147/COPD.S160842. eCollection 2018.

16.

Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study.

Calle Rubio M, Soriano JB, López-Campos JL, Soler-Cataluña JJ, Alcázar Navarrete B, Rodríguez González-Moro JM, Miravitlles M, Barrecheguren M, Fuentes Ferrer ME, Rodriguez Hermosa JL; EPOCONSUL Study.

PLoS One. 2018 Jun 28;13(6):e0198777. doi: 10.1371/journal.pone.0198777. eCollection 2018. Erratum in: PLoS One. 2019 Feb 12;14(2):e0212522.

17.

Creation of the SAQ-COPD Questionnaire to Determine Physical Activity in COPD Patients in Clinical Practice.

Soler-Cataluña JJ, Puente Maestu L, Román-Rodríguez M, Esteban C, Gea J, Bernabeu Mora R, Pleguezuelos Cobo E, Ancochea J, Monteagudo Ruiz G, Garcia Rio F.

Arch Bronconeumol. 2018 Sep;54(9):467-475. doi: 10.1016/j.arbres.2018.01.016. Epub 2018 Mar 13. English, Spanish.

18.

Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD.

Miravitlles M, Sliwinski P, Rhee CK, Costello RW, Carter V, Tan J, Lapperre TS, Alcazar B, Gouder C, Esquinas C, García-Rivero JL, Kemppinen A, Tee A, Roman-Rodríguez M, Soler-Cataluña JJ, Price DB.

Respir Med. 2018 Mar;136:8-14. doi: 10.1016/j.rmed.2018.01.019. Epub 2018 Jan 31.

PMID:
29501251
19.

Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease.

Guerra B, Haile SR, Lamprecht B, Ramírez AS, Martinez-Camblor P, Kaiser B, Alfageme I, Almagro P, Casanova C, Esteban-González C, Soler-Cataluña JJ, de-Torres JP, Miravitlles M, Celli BR, Marin JM, Ter Riet G, Sobradillo P, Lange P, Garcia-Aymerich J, Antó JM, Turner AM, Han MK, Langhammer A, Leivseth L, Bakke P, Johannessen A, Oga T, Cosio B, Ancochea-Bermúdez J, Echazarreta A, Roche N, Burgel PR, Sin DD, Soriano JB, Puhan MA; 3CIA collaboration.

BMC Med. 2018 Mar 2;16(1):33. doi: 10.1186/s12916-018-1013-y.

20.

Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.

de Llano LP, Cosío BG, Iglesias A, de Las Cuevas N, Soler-Cataluña JJ, Izquierdo JL, López-Campos JL, Calero C, Plaza V, Miravitlles M, Torrego A, Martinez-Moragon E, Soriano JB, Viña AL, Bobolea I.

Int J Chron Obstruct Pulmon Dis. 2018 Feb 12;13:591-601. doi: 10.2147/COPD.S153694. eCollection 2018.

21.

Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (Gesepoc): The Epoconsul Study.

Calle Rubio M, Rodríguez Hermosa JL, Soler-Cataluña JJ, López-Campos JL, Alcazar Navarrete B, Soriano JB, Rodríguez Gónzalez-Moro JM, Fuentes Ferrer ME, Miravitlles M; y el Grupo Epoconsul.

Arch Bronconeumol. 2018 May;54(5):270-279. doi: 10.1016/j.arbres.2017.11.015. Epub 2018 Feb 1. English, Spanish.

22.

Variability in adherence to clinical practice guidelines and recommendations in COPD outpatients: a multi-level, cross-sectional analysis of the EPOCONSUL study.

Calle Rubio M, López-Campos JL, Soler-Cataluña JJ, Alcázar Navarrete B, Soriano JB, Rodríguez González-Moro JM, Fuentes Ferrer ME, Rodríguez Hermosa JL; EPOCONSUL Study.

Respir Res. 2017 Dec 2;18(1):200. doi: 10.1186/s12931-017-0685-8.

23.

Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD.

Casanova C, Celli BR, de-Torres JP, Martínez-Gonzalez C, Cosio BG, Pinto-Plata V, de Lucas-Ramos P, Divo M, Fuster A, Peces-Barba G, Calle-Rubio M, Solanes I, Aguero R, Feu-Collado N, Alfageme I, De Diego A, Romero A, Balcells E, Llunell A, Galdiz JB, Marin M, Moreno A, Cabrera C, Golpe R, Lacarcel C, Soriano JB, López-Campos JL, Soler-Cataluña JJ, Marin JM.

Eur Respir J. 2017 Nov 22;50(5). pii: 1701162. doi: 10.1183/13993003.01162-2017. Print 2017 Nov.

24.

Clinical practice guidelines or personalized medicine in chronic obstructive pulmonary disease?

Soler-Cataluña JJ.

Arch Bronconeumol. 2018 May;54(5):247-248. doi: 10.1016/j.arbres.2017.08.002. Epub 2017 Nov 3. English, Spanish. No abstract available.

25.

A simple algorithm for the identification of clinical COPD phenotypes.

Burgel PR, Paillasseur JL, Janssens W, Piquet J, Ter Riet G, Garcia-Aymerich J, Cosio B, Bakke P, Puhan MA, Langhammer A, Alfageme I, Almagro P, Ancochea J, Celli BR, Casanova C, de-Torres JP, Decramer M, Echazarreta A, Esteban C, Gomez Punter RM, Han MK, Johannessen A, Kaiser B, Lamprecht B, Lange P, Leivseth L, Marin JM, Martin F, Martinez-Camblor P, Miravitlles M, Oga T, Sofia Ramírez A, Sin DD, Sobradillo P, Soler-Cataluña JJ, Turner AM, Verdu Rivera FJ, Soriano JB, Roche N; Initiatives BPCO, EABPCO, Leuven and 3CIA study groups.

Eur Respir J. 2017 Nov 2;50(5). pii: 1701034. doi: 10.1183/13993003.01034-2017. Print 2017 Nov.

26.

Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensus.

Miravitlles M, Soler-Cataluña JJ, Alcázar B, Viejo JL, García-Río F.

Pulm Pharmacol Ther. 2018 Feb;48:97-103. doi: 10.1016/j.pupt.2017.10.006. Epub 2017 Oct 12.

PMID:
29031616
27.

Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus.

García-Río F, Soler-Cataluña JJ, Alcazar B, Viejo JL, Miravitlles M.

COPD. 2017 Dec;14(6):573-580. doi: 10.1080/15412555.2017.1365120. Epub 2017 Sep 11.

PMID:
28891722
28.

Validating the Concept of COPD Control: A Real-world Cohort Study from the United Kingdom.

Nibber A, Chisholm A, Soler-Cataluña JJ, Alcazar B, Price D, Miravitlles M.

COPD. 2017 Oct;14(5):504-512. doi: 10.1080/15412555.2017.1350154. Epub 2017 Aug 16.

PMID:
28813176
29.

Palliative care and prognosis in COPD: a systematic review with a validation cohort.

Almagro P, Yun S, Sangil A, Rodríguez-Carballeira M, Marine M, Landete P, Soler-Cataluña JJ, Soriano JB, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 9;12:1721-1729. doi: 10.2147/COPD.S135657. eCollection 2017. Review.

30.

Consensus on the Asthma-COPD Overlap Syndrome (ACOS) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA).

Plaza V, Álvarez F, Calle M, Casanova C, Cosío BG, López-Viña A, Pérez de Llano L, Quirce S, Román-Rodríguez M, Soler-Cataluña JJ, Miravitlles M.

Arch Bronconeumol. 2017 Aug;53(8):443-449. doi: 10.1016/j.arbres.2017.04.002. Epub 2017 May 8. English, Spanish.

31.

Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase.

Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, Trigueros JA, Cosío BG, Casanova C, Antonio Riesco J, Simonet P, Rigau D, Soriano JB, Ancochea J.

Arch Bronconeumol. 2017 Jun;53(6):324-335. doi: 10.1016/j.arbres.2017.03.018. Epub 2017 May 3. English, Spanish.

32.

Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines.

Miravitlles M, Alvarez-Gutierrez FJ, Calle M, Casanova C, Cosio BG, López-Viña A, Pérez de Llano L, Quirce S, Roman-Rodríguez M, Soler-Cataluña JJ, Plaza V.

Eur Respir J. 2017 May 1;49(5). pii: 1700068. doi: 10.1183/13993003.00068-2017. Print 2017 May. No abstract available.

33.

Clinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL study.

Calle Rubio M, Alcázar Navarrete B, Soriano JB, Soler-Cataluña JJ, Rodríguez González-Moro JM, Fuentes Ferrer ME, López-Campos JL.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 25;12:417-426. doi: 10.2147/COPD.S124482. eCollection 2017.

34.

GOLD in 2017: A View From the Spanish COPD Guidelines (GesCOPD).

Miravitlles M, Soler-Cataluña JJ.

Arch Bronconeumol. 2017 Mar;53(3):89-90. doi: 10.1016/j.arbres.2017.01.001. Epub 2017 Jan 31. English, Spanish. No abstract available.

35.

Prognostic assessment in COPD without lung function: the B-AE-D indices.

Boeck L, Soriano JB, Brusse-Keizer M, Blasi F, Kostikas K, Boersma W, Milenkovic B, Louis R, Lacoma A, Djamin R, Aerts J, Torres A, Rohde G, Welte T, Martinez-Camblor P, Rakic J, Scherr A, Koller M, van der Palen J, Marin JM, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Miravitlles M, Celli BR, Tamm M, Stolz D.

Eur Respir J. 2016 Jun;47(6):1635-44. doi: 10.1183/13993003.01485-2015. Epub 2016 Apr 21.

36.

The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS).

Miravitlles M, Worth H, Soler-Cataluña JJ, Price D, De Benedetto F, Roche N, Godtfredsen NS, van der Molen T, Löfdahl CG, Padullés L, Ribera A.

COPD. 2016 Oct;13(5):561-8. doi: 10.3109/15412555.2016.1150447. Epub 2016 Mar 16.

PMID:
26983349
37.

Prevalence and Perception of 24-Hour Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain.

Soler-Cataluña JJ, Sauleda J, Valdés L, Marín P, Agüero R, Pérez M, Miravitlles M.

Arch Bronconeumol. 2016 Jun;52(6):308-15. doi: 10.1016/j.arbres.2015.11.010. Epub 2016 Jan 7. English, Spanish.

38.

Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort.

Cosio BG, Soriano JB, López-Campos JL, Calle-Rubio M, Soler-Cataluna JJ, de-Torres JP, Marín JM, Martínez-Gonzalez C, de Lucas P, Mir I, Peces-Barba G, Feu-Collado N, Solanes I, Alfageme I, Casanova C; CHAIN Study.

Chest. 2016 Jan;149(1):45-52. doi: 10.1378/chest.15-1055. Epub 2016 Jan 6.

PMID:
26291753
39.

What pulmonologists think about the asthma-COPD overlap syndrome.

Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C, Cisneros C, de-Torres JP, Entrenas LM, Esteban C, García-Sidro P, Cosio BG, Huerta A, Iriberri M, Izquierdo JL, López-Viña A, López-Campos JL, Martínez-Moragón E, Pérez de Llano L, Perpiñá M, Ros JA, Serrano J, Soler-Cataluña JJ, Torrego A, Urrutia I, Plaza V.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 15;10:1321-30. doi: 10.2147/COPD.S88667. eCollection 2015.

40.

Evaluation of the COPD Assessment Test and GOLD patient types: a cross-sectional analysis.

Lopez-Campos JL, Fernandez-Villar A, Calero-Acuña C, Represas-Represas C, Lopez-Ramírez C, Fernández VL, Soler-Cataluña JJ, Casamor R; On-Sint study group.

Int J Chron Obstruct Pulmon Dis. 2015 May 27;10:975-84. doi: 10.2147/COPD.S82781. eCollection 2015.

41.

Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data.

Soriano JB, Lamprecht B, Ramírez AS, Martinez-Camblor P, Kaiser B, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Miravitlles M, Celli BR, Marin JM, Puhan MA, Sobradillo P, Lange P, Sternberg AL, Garcia-Aymerich J, Turner AM, Han MK, Langhammer A, Leivseth L, Bakke P, Johannessen A, Roche N, Sin DD.

Lancet Respir Med. 2015 Jun;3(6):443-50. doi: 10.1016/S2213-2600(15)00157-5. Epub 2015 May 17.

PMID:
25995071
42.

Does the COPD assessment test (CAT(TM)) questionnaire produce similar results when self- or interviewer administered?

Agusti A, Soler-Cataluña JJ, Molina J, Morejon E, Garcia-Losa M, Roset M, Badia X.

Qual Life Res. 2015 Oct;24(10):2345-54. doi: 10.1007/s11136-015-0983-x. Epub 2015 Apr 7.

PMID:
25846413
43.

Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.

Casanova C, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B, Peces-Barba G, Solanes-García I, Agüero R, Feu-Collado N, Calle-Rubio M, Alfageme I, de Diego-Damia A, Irigaray R, Marín M, Balcells E, Llunell A, Galdiz JB, Golpe R, Lacarcel C, Cabrera C, Marin A, Soriano JB, Lopez-Campos JL, Soler-Cataluña JJ, de-Torres JP; COPD History Assessment in Spain (CHAIN) Cohort.

Chest. 2015 Jul;148(1):159-168. doi: 10.1378/chest.14-2449.

PMID:
25612228
44.

The role of pulmonology in the National Health System Chronicity Strategy.

Soler-Cataluña JJ, Sánchez Toril F, Aguar Benito MC.

Arch Bronconeumol. 2015 Aug;51(8):396-402. doi: 10.1016/j.arbres.2014.10.007. Epub 2014 Dec 29. English, Spanish.

45.

Assessment of the internal structure of GOLD 2011 system.

Rodrigo GJ, Soler-Cataluña JJ, Solanes I, Bolibar I, Llauger MA, Plaza V.

Pulm Pharmacol Ther. 2015 Feb;30:87-92. doi: 10.1016/j.pupt.2014.12.002. Epub 2014 Dec 27.

PMID:
25549570
46.

The concept of control of COPD in clinical practice.

Soler-Cataluña JJ, Alcázar-Navarrete B, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2014 Dec 12;9:1397-405. doi: 10.2147/COPD.S71370. eCollection 2014.

47.

Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?

Echave-Sustaeta JM, Comeche Casanova L, Cosio BG, Soler-Cataluña JJ, Garcia-Lujan R, Ribera X.

Int J Chron Obstruct Pulmon Dis. 2014 Nov 19;9:1307-14. doi: 10.2147/COPD.S71849. eCollection 2014.

48.

Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study.

Miravitlles M, Worth H, Soler Cataluña JJ, Price D, De Benedetto F, Roche N, Godtfredsen NS, van der Molen T, Löfdahl CG, Padullés L, Ribera A.

Respir Res. 2014 Oct 21;15:122. doi: 10.1186/s12931-014-0122-1.

49.

Finding the best thresholds of FEV1 and dyspnea to predict 5-year survival in COPD patients: the COCOMICS study.

Almagro P, Martinez-Camblor P, Soriano JB, Marin JM, Alfageme I, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Celli BR, Miravitlles M.

PLoS One. 2014 Feb 27;9(2):e89866. doi: 10.1371/journal.pone.0089866. eCollection 2014.

50.

Clinical application of the COPD assessment test: longitudinal data from the COPD History Assessment in Spain (CHAIN) cohort.

de Torres JP, Marin JM, Martinez-Gonzalez C, de Lucas-Ramos P, Mir-Viladrich I, Cosio B, Peces-Barba G, Calle-Rubio M, Solanes-García I, Agüero Balbin R, de Diego-Damia A, Feu-Collado N, Alfageme Michavila I, Irigaray R, Balcells E, Llunell Casanovas A, Galdiz Iturri JB, Marín Royo M, Soler-Cataluña JJ, Lopez-Campos JL, Soriano JB, Casanova C; COPD History Assessment in Spain (CHAIN) Cohort*.

Chest. 2014 Jul;146(1):111-122. doi: 10.1378/chest.13-2246.

PMID:
24522636

Supplemental Content

Loading ...
Support Center